- Home
- PCYO vs ENGN Comparison
PCYO vs ENGN Comparison
Compare PCYO & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- ENGN
- Stock Information
- Founded
- PCYO 1976
- ENGN 1999
- Country
- PCYO United States
- ENGN Canada
- Employees
- PCYO N/A
- ENGN N/A
- Industry
- PCYO Water Supply
- ENGN
- Sector
- PCYO Utilities
- ENGN
- Exchange
- PCYO Nasdaq
- ENGN Nasdaq
- Market Cap
- PCYO 307.4M
- ENGN 293.1M
- IPO Year
- PCYO N/A
- ENGN N/A
- Fundamental
- Price
- PCYO $12.76
- ENGN $7.63
- Analyst Decision
- PCYO
- ENGN Strong Buy
- Analyst Count
- PCYO 0
- ENGN 6
- Target Price
- PCYO N/A
- ENGN $33.67
- AVG Volume (30 Days)
- PCYO 43.3K
- ENGN 99.5K
- Earning Date
- PCYO 11-13-2024
- ENGN 09-10-2024
- Dividend Yield
- PCYO N/A
- ENGN N/A
- EPS Growth
- PCYO 152.63
- ENGN N/A
- EPS
- PCYO 0.48
- ENGN N/A
- Revenue
- PCYO $28,747,000.00
- ENGN N/A
- Revenue This Year
- PCYO N/A
- ENGN N/A
- Revenue Next Year
- PCYO N/A
- ENGN N/A
- P/E Ratio
- PCYO $26.58
- ENGN N/A
- Revenue Growth
- PCYO 97.09
- ENGN N/A
- 52 Week Low
- PCYO $8.94
- ENGN $4.42
- 52 Week High
- PCYO $13.40
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- PCYO 69.09
- ENGN 42.76
- Support Level
- PCYO $11.50
- ENGN $7.82
- Resistance Level
- PCYO $13.40
- ENGN $8.61
- Average True Range (ATR)
- PCYO 0.51
- ENGN 0.56
- MACD
- PCYO 0.15
- ENGN -0.19
- Stochastic Oscillator
- PCYO 78.31
- ENGN 1.18
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.